ZR2 BIOENERGY LIMITED Stock Price Today (NSE: ZR2)

ZR2 BIOENERGY LIMITED

136.900.65 (0.47%)
Market Closed

Fundamental Score

...

ZR2 BIOENERGY LIMITED Share Price — Live NSE/BSE Price, Fundamentals & Analysis

ZR2 BIOENERGY LIMITED share price today is 136.90, down 0.47% on NSE/BSE as of 18 September 2026. ZR2 BIOENERGY LIMITED (ZR2) is a Small-cap company in the Commodity Chemicals sector with a market capitalisation of 48.86 (Cr). The 52-week high for ZR2 share price is 413.80 and the 52-week low is 90.00. 0

ZR2 BIOENERGY LIMITED Share Price Chart — NSE/BSE Historical Performance

No data
High
136.90
Low
103.00
Volume
133.57142857142858
Change
+13.16%

ZR2 BIOENERGY LIMITED share price chart: 13.16% return over the past month. 52-week high ₹413.80, 52-week low ₹90.00.

ZR2 BIOENERGY LIMITED — Last 10 Trading Days

DateOpenHighLowCloseVolume
137.55144.40131.00136.901.10K (Cr)
137.55137.55137.00137.55244.00 (Cr)
134.40134.40127.00131.009.62K (Cr)
130.00130.00127.90128.0052.00 (Cr)
122.35128.45116.25125.85215.00 (Cr)
114.25122.35114.25122.35576.00 (Cr)
117.90117.90116.55116.5520.00 (Cr)
117.00117.90117.00117.9049.00 (Cr)
119.55119.55117.90118.0032.00 (Cr)
114.75114.75114.00114.55115.00 (Cr)

ZR2 BIOENERGY LIMITED — Last 12 Months Price History

MonthOpenHighLowCloseChange
114.85144.40103.70136.90+19.20%
99.80130.0094.00115.55+15.78%
110.00135.00104.10104.10-5.36%
149.70157.5095.80105.30-29.66%
148.55156.50136.00144.00-3.06%
102.99178.00102.99147.66+43.37%
139.50149.7590.0098.45-29.43%
146.10174.00130.65139.50-4.52%
289.90299.00135.00166.00-42.74%
325.00328.80243.35290.00-10.77%
366.00369.00256.95306.00-16.39%
375.00392.00255.00317.35-15.37%

Returns & Performance

Poor

Return on Equity (ROE)

0.00%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

0.70%

Returns generated on total capital deployed

Oper. Profit Margin (5Y Avg)

N/A

Average operating profit margin over 5 years

Dividend Yield

0.08%

Annual dividend as % of current share price

ZR2 BIOENERGY LIMITED Valuation Check

Price to Earnings (P/E)

N/A

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

22.30x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

61.00%

% shares held by company founders/management

Poor

FII Holding

0.00%

% shares held by foreign institutional investors

Poor

DII Holding

0.06%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Poor

Profit Growth (Quarterly YoY)

-100.00%

Net profit growth vs same quarter last year

Revenue Growth (Quarterly YoY)

N/A

Revenue growth vs same quarter last year

Revenue Growth (5-Year CAGR)

N/A

Compounded annual revenue growth over 5 years

EPS Growth (5-Year CAGR)

N/A

Earnings per share growth over 5 years

Net Profit Growth (5-Year CAGR)

N/A

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.00x

Total debt ÷ equity. Below 0.5 = financially healthy

Excellent

Interest Coverage Ratio

1218.38x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

N/A

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

ZR2 BIOENERGY LIMITED Fundamental Analysis & Valuation Benchmarking

Educational evaluation of ZR2 across key market metrics for learning purposes.

Positive Indicators

5 factors identified

Debt-Free Balance Sheet (D/E: 0.00)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Strong Interest Coverage (1218.38x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk.

Healthy Liquidity Position (Current Ratio: 126.65)

Observation: Strong short-term liquidity to meet obligations.

Analysis: Current ratio >1.5 indicates good working capital management.

Balanced Promoter Holding (61.00%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

4 factors identified

Below-Average Return on Equity (0.00%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Suboptimal ROCE (0.70%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.

Profit Decline Concern (-100.00%)

Observation: Significant year-over-year profit contraction observed.

Analysis: Declining profitability requires investigation into underlying causes.

Limited Institutional Interest (FII+DII: 0.06%)

Observation: Low institutional participation may affect liquidity.

Analysis: Limited institutional interest may indicate size constraints or visibility issues.

ZR2 BIOENERGY LIMITED vs Commodity Chemicals Peers

Peer Comparison - Commodity Chemicals

Compare ZR2 BIOENERGY LIMITED with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
19/100
137
₹48.86
0.00%
Poor
0.70%
Poor
0.0
Excellent
0.08%
49.2/100
2524
₹74804.55
34.6
Average
0.00%
Poor
15.29%
Good
0.4
Excellent
9.70%
Good
13.45%
Good
0.32%
34.6/100
1345
₹16979.28
17.3
Average
11.27%
Average
12.57%
Average
0.8
Good
12.99%
Good
14.65%
Good
0.65%
16.3/100
607
₹15486.15
-8.86%
Poor
-3.24%
Poor
0.4
Excellent
2.85%
Average
7.41%
Good
1.58%
56.5/100
567
₹8340.78
8.0
Average
0.00%
Poor
10.62%
Average
0.0
Excellent
3.00%
Average
8.67%
Good
3.61%
56/100
3468
₹6918.06
102.3
Average
20.47%
Excellent
27.28%
Excellent
0.2
Excellent
32.34%
Excellent
36.90%
Excellent
0.18%
32.9/100
713
₹5236.27
78.9
Average
0.00%
Poor
1.58%
Poor
0.1
Excellent
12.40%
Good
2.66%
38.9/100
424
₹3906.77
7.6
Average
13.42%
Average
16.97%
Good
0.0
Excellent
7.70%
Good
1.11%
Average
2.75%
67.5/100
73
₹3609.71
22.0
Average
16.23%
Good
21.35%
Excellent
0.0
Excellent
19.92%
Excellent
14.48%
Good
0.63%
18.4/100
178
₹2820.23
0.00%
Poor
-3.82%
Poor
1.1
Average
2.14%
Average
0.00%
66.7/100
595
₹2330.98
31.0
Average
13.27%
Average
21.98%
Excellent
0.0
Excellent
23.80%
Excellent
17.52%
Excellent
0.23%

ZR2 BIOENERGY LIMITED PE Ratio History

Historical price-to-earnings ratio for ZR2 — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 20241.24₹415.55335.1x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

ZR2 BIOENERGY LIMITED Quarterly Performance

Latest quarterly metrics for ZR2 — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

N/A

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

-100.00%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

N/A

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

N/A

Compounded annual net profit growth over 5 years

ZR2 BIOENERGY LIMITED Technical Indicators

SMA 50, SMA 200, RSI and volume signals for ZR2 — calculated from daily price history

38RSI 14
Neutral — RSI 38

Momentum is balanced — neither overbought nor oversold.

SMA 50
115
▲ Price above SMA 50 — Short-term bullish
SMA 200
163
▼ Price below SMA 200 — Long-term downtrend
30-Day Avg Volume
0K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

ZR2 BIOENERGY LIMITED Financial Statements

Annual income statement, balance sheet and cash flow for ZR2 BIOENERGY LIMITED (ZR2) — sourced from NSE/BSE filings.

Financial Results & Statements

Latest quarterly, annual and period-wise financial data for ZR2 BIOENERGY LIMITED

Loading latest quarterly results...

About ZR2 (ZR2 BIOENERGY LIMITED)

ZR2 BIOENERGY LIMITED is a pioneering force in the commodity chemicals sector, revolutionizing the production of essential resources through sustainable and innovative bioenergy so...lutions. The company is dedicated to transforming organic waste and agricultural byproducts into valuable commodities that fuel industries and contribute to a greener future. ZR2's commitment to environmental stewardship is reflected in its state-of-the-art facilities and proprietary processes, maximizing efficiency and minimizing its carbon footprint. With a focus on quality and consistency, ZR2 Bioenergy delivers a reliable supply of high-grade bio-based products to meet the growing demands of a rapidly evolving market. ZR2 specializes in the manufacturing of three core commodity chemicals: compressed biogas, a clean-burning renewable energy source; ethanol, a versatile biofuel and industrial solvent; and potash, a crucial ingredient in fertilizers that supports global food production. These products are carefully crafted from responsibly sourced biomass, ensuring both environmental integrity and superior performance. Through rigorous research and development, ZR2 continuously refines its production methods to optimize yields and enhance the quality of its offerings. By embracing circular economy principles, ZR2 strives to minimize waste and maximize resource utilization, demonstrating a commitment to sustainable practices across its entire value chain. Rooted in a rich legacy dating back to 1911, ZR2 Bioenergy Limited has evolved from its origins as Gujchem Distillers India Limited to become a leader in the bioenergy revolution. Officially rebranded in May 2025, the company's headquarters remain strategically located in Mumbai, India, a vibrant hub for innovation and commerce. With a deeply ingrained understanding of the local market and a global perspective, ZR2 is poised to capitalize on the growing demand for sustainable commodity chemicals. Its enduring commitment to quality, innovation, and environmental responsibility positions ZR2 Bioenergy Limited as a trusted partner and a driving force in the transition towards a more sustainable future.

Company Details

Symbol:ZR2
Industry:Commodity Chemicals
Sector:Commodity Chemicals

Key Leadership

Mr. Jimmy Olsson
MD & Chairman
Mr. Mahendra Surajbhan Agarwal
Chief Financial Officer
Ms. Shital Suresh Gurav
Company Secretary & Compliance Officer

ZR2 Share Price: Frequently Asked Questions

What is the current share price of ZR2 BIOENERGY LIMITED?

ZR2 BIOENERGY LIMITED (ZR2) trades at ₹136.90 on NSE and BSE. Market cap ₹48.86 (Cr). Educational data only.

What is the P/E ratio of ZR2 BIOENERGY LIMITED?

ZR2 BIOENERGY LIMITED has a P/E of N/Ax vs industry average 22.30x.

What is the Bull Run score for ZR2 BIOENERGY LIMITED?

ZR2 BIOENERGY LIMITED has a Bull Run score of 19/100 based on 25+ financial parameters.

Does ZR2 BIOENERGY LIMITED pay dividends?

ZR2 BIOENERGY LIMITED has a dividend yield of 0.08%. Past dividends don't guarantee future payments.

What is the ROE of ZR2 BIOENERGY LIMITED?

ZR2 BIOENERGY LIMITED has ROE of 0.00%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of ZR2 BIOENERGY LIMITED?

ZR2 BIOENERGY LIMITED has debt-to-equity of 0.00.

Is ZR2 BIOENERGY LIMITED a good investment?

Bull Run gives ZR2 BIOENERGY LIMITED a score of 19/100. This is not investment advice — consult a SEBI-registered advisor.